← all works
Retraction Note: Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Post-publication record
OpenAlex flags this work as retracted, but it carries no matching Retraction Watch record in this frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Pharmaceutical Research
- Topic
- Graphene and Nanomaterials Applications
- Field
- Engineering
- Canadian institutions
- University of Alberta
- Funders
- —
- Keywords
- ChitosanChemistryCancer researchNanoparticleCellCancerMedicineNanotechnologyMaterials scienceBiochemistryInternal medicine
- Has abstract in OpenAlex
- no